search
Back to results

Improving Mood in Veterans in Primary Care

Primary Purpose

Depression

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Brief Behavioral Activation
Usual Care
Sponsored by
VA Office of Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression focused on measuring Depression, Behavioral Symptoms, Mental Disorders, Depressive Disorder, suicidal ideation, primary health care, Veterans

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Veterans:

  • aged 18 years
  • seeking or receiving primary care services at the Syracuse, Canandaigua, or Buffalo VA Medical Centers
  • reporting at least moderate depressive symptoms
  • stable course of antidepression medications
  • stable course of outpatient treatment for anxiety or substance use disorders

Exclusion Criteria:

Veterans who are:

  • unable to demonstrate an understanding of the informed consent
  • non-English speaking
  • reporting imminent risk of suicide
  • have an unstable psychiatric condition
  • currently involved in treatment for depression
  • recently started antidepression medication or outpatient treatment for anxiety or substance use disorder
  • currently involved or completed inpatient or intensive outpatient treatment

Sites / Locations

  • VA Western New York Healthcare System, Buffalo, NY
  • Canandaigua VA Medical Center, Canandaigua, NY
  • Syracuse VA Medical Center, Syracuse, NY

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Brief Behavioral Activation

Usual Care

Arm Description

This is a 4-session individual workshop using behavioral activation techniques. Emphasis is placed upon understanding the individuals values and increasing the number of pleasurable activities aligned with the individuals values.

This is the usual care condition, where participants often times will be provided with brief treatment in primary care that can take many forms.

Outcomes

Primary Outcome Measures

Change From Baseline in Depressive Symptoms at 12 Weeks
The investigators will use the Patient Health Questionnaire-9 (PHQ-9) to assess depressive symptoms at baseline and 12 weeks. The minimum value is 0 and the maximum value is 27. Higher scores mean a worse outcome.

Secondary Outcome Measures

Change From Baseline in Quality of Life at 12 Weeks
The investigators will use the Short Form-12 (SF-12) mental health domain to assess quality of life at baseline and 12 weeks. The minimum score is 0 and maximum score is 100. Higher scores mean better quality of life within mental health domain.
Change From Baseline in Sleep Disturbances at 12 Weeks
The investigators will use the Insomnia Severity Index (ISI) to assess sleep disturbances at baseline and 12 weeks. The minimum score is 0 and the maximum score is 28. Higher scores on ISI mean worse sleep.
Change From Baseline in the Level of Reward/Positive Mood When Engaging in Various Experiences at 12 Weeks
The investigators will use the Environmental Observational Reward (EROS) scale to assess level of reward/positive mood at baseline and 12 weeks. The minimum score is 10 and the maximum score is 40. Higher scores mean increased level of positive mood obtained from environment.

Full Information

First Posted
October 8, 2014
Last Updated
June 19, 2019
Sponsor
VA Office of Research and Development
search

1. Study Identification

Unique Protocol Identification Number
NCT02276807
Brief Title
Improving Mood in Veterans in Primary Care
Official Title
RCT of Behavioral Activation for Depression and Suicidality in Primary Care
Study Type
Interventional

2. Study Status

Record Verification Date
June 2019
Overall Recruitment Status
Completed
Study Start Date
March 23, 2015 (Actual)
Primary Completion Date
March 1, 2018 (Actual)
Study Completion Date
July 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the Improving Mood in Veterans in Primary Care (IIR 14-047) is to evaluate a brief educational individual workshop that is meant to help Veterans better understand feelings of sadness and ways to improve their mood. This study is intended to evaluate and establish the workshop's effectiveness for use with Veterans in primary care settings. The study involves up to 6 in-person meetings and 6 telephone interviews across a 6-month period of time. Approximately 144 Veterans will participate in the study. Using a procedure like the flip of a coin, the participants will have a one in two chance of receiving the brief educational workshop or treatment as usual condition.
Detailed Description
Background: Depressive symptoms are the most common referral problem to integrated mental health providers within Veteran primary care clinics. Although there exist several empirically-based brief psychotherapies for depression in primary care, the most significant barrier to providing those psychotherapies is treatment duration (e.g., the treatments range from 6-8 sessions of 30-50 minutes) as it does not match typical treatment formats delivered by mental health providers working in primary care (i.e., 1-4 15-30 minute sessions). Therefore, this HSR&D study titled, RCT of Behavioral Activation for Depression and Suicidality in Primary Care, will examine the effectiveness of a brief version of an existing efficacious longer treatment for depression, called behavioral activation. Objectives: The overarching objectives of this study are to: 1) examine whether a 4-session manualized behavioral activation intervention (BA-PC) compared to Treatment as Usual (TAU) is effective in reducing self-reported depressive symptoms and subjective secondary outcomes such as sleep impairment and quality of life; 2) examine patient satisfaction, engagement, and receptivity to a 4-session BA-PC; and 3) explore the impact of BA-PC on suicidal ideation. Methods: The study will achieve these objectives using a randomized, controlled trial study design that has two conditions (4-session BA-PC and Treatment as Usual). Veterans will be recruited from three VA primary care settings in the Western portion of VISN 2 (Syracuse, Rochester, and Buffalo). The primary inclusion criteria for the study will be a report of depressive symptoms by primary care patients, who are not currently engaged in psychological treatment for depression. A total of 136 Veterans will be targeted for randomization. All Veterans will be assessed every 2 weeks for changes in mood and more comprehensive assessments will be completed at 6, 12, and 24 weeks. Status: Recruitment has ended as of 2/26/18 with 140 participants being randomized. Follow-up will continue for another 24 weeks. We are preparing the data for analysis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression
Keywords
Depression, Behavioral Symptoms, Mental Disorders, Depressive Disorder, suicidal ideation, primary health care, Veterans

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
140 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Brief Behavioral Activation
Arm Type
Experimental
Arm Description
This is a 4-session individual workshop using behavioral activation techniques. Emphasis is placed upon understanding the individuals values and increasing the number of pleasurable activities aligned with the individuals values.
Arm Title
Usual Care
Arm Type
Active Comparator
Arm Description
This is the usual care condition, where participants often times will be provided with brief treatment in primary care that can take many forms.
Intervention Type
Behavioral
Intervention Name(s)
Brief Behavioral Activation
Intervention Description
This is a 4-session individual workshop using behavioral activation techniques.
Intervention Type
Other
Intervention Name(s)
Usual Care
Other Intervention Name(s)
Usual Care condition
Intervention Description
Primary care patients will be referred to the integrated behavioral health provider to receive brief treatment in primary care.
Primary Outcome Measure Information:
Title
Change From Baseline in Depressive Symptoms at 12 Weeks
Description
The investigators will use the Patient Health Questionnaire-9 (PHQ-9) to assess depressive symptoms at baseline and 12 weeks. The minimum value is 0 and the maximum value is 27. Higher scores mean a worse outcome.
Time Frame
Baseline and 12 weeks
Secondary Outcome Measure Information:
Title
Change From Baseline in Quality of Life at 12 Weeks
Description
The investigators will use the Short Form-12 (SF-12) mental health domain to assess quality of life at baseline and 12 weeks. The minimum score is 0 and maximum score is 100. Higher scores mean better quality of life within mental health domain.
Time Frame
Baseline and 12 weeks
Title
Change From Baseline in Sleep Disturbances at 12 Weeks
Description
The investigators will use the Insomnia Severity Index (ISI) to assess sleep disturbances at baseline and 12 weeks. The minimum score is 0 and the maximum score is 28. Higher scores on ISI mean worse sleep.
Time Frame
Baseline and 12 weeks
Title
Change From Baseline in the Level of Reward/Positive Mood When Engaging in Various Experiences at 12 Weeks
Description
The investigators will use the Environmental Observational Reward (EROS) scale to assess level of reward/positive mood at baseline and 12 weeks. The minimum score is 10 and the maximum score is 40. Higher scores mean increased level of positive mood obtained from environment.
Time Frame
Baseline and 12 weeks
Other Pre-specified Outcome Measures:
Title
Change From Baseline in the Level of Intensity of Suicidal Ideation at 12 Weeks
Description
The investigators will use the Beck Scale for Suicidal Ideation to assess intensity of suicidal ideation within the past week at baseline and 12 weeks. The minimum score is 0 and the maximum score is 38. Higher scores mean worse suicidal ideation.
Time Frame
Baseline and 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Veterans: aged 18 years seeking or receiving primary care services at the Syracuse, Canandaigua, or Buffalo VA Medical Centers reporting at least moderate depressive symptoms stable course of antidepression medications stable course of outpatient treatment for anxiety or substance use disorders Exclusion Criteria: Veterans who are: unable to demonstrate an understanding of the informed consent non-English speaking reporting imminent risk of suicide have an unstable psychiatric condition currently involved in treatment for depression recently started antidepression medication or outpatient treatment for anxiety or substance use disorder currently involved or completed inpatient or intensive outpatient treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer Schum Funderburk, PhD
Organizational Affiliation
Syracuse VA Medical Center, Syracuse, NY
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Western New York Healthcare System, Buffalo, NY
City
Buffalo
State/Province
New York
ZIP/Postal Code
14215
Country
United States
Facility Name
Canandaigua VA Medical Center, Canandaigua, NY
City
Canandaigua
State/Province
New York
ZIP/Postal Code
14424
Country
United States
Facility Name
Syracuse VA Medical Center, Syracuse, NY
City
Syracuse
State/Province
New York
ZIP/Postal Code
13210
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
33516082
Citation
Funderburk JS, Pigeon WR, Shepardson RL, Wade M, Acker J, Fivecoat H, Wray LO, Maisto SA. Treating depressive symptoms among veterans in primary care: A multi-site RCT of brief behavioral activation. J Affect Disord. 2021 Mar 15;283:11-19. doi: 10.1016/j.jad.2021.01.033. Epub 2021 Jan 14.
Results Reference
derived
Links:
URL
http://www.mirecc.va.gov/cih-visn2/
Description
The co-PI's are affiliated with the VA Center for Integrated Healthcare and this website describes current and past research projects similar to the one in this study.
URL
http://www.hsrd.research.va.gov
Description
Click here for more information about this study: RCT of Behavioral Activation for Depression and Suicidality in Primary Care

Learn more about this trial

Improving Mood in Veterans in Primary Care

We'll reach out to this number within 24 hrs